Personal information
cancer immunology, cancer Immunotherapy, T cells, tumor microenvironment, checkpoint inhibition, cellular therapies
Switzerland
Activities
Employment (1)
Employment
Source:
Zippelius A
Education and qualifications (4)
2007
to
present
|
Clinical Specialization Medical Oncology
Qualification
Source:
Zippelius A
2006
to
present
|
Habilitation
Qualification
Source:
Zippelius A
1997
|
MD PhD
(Immunology)
Qualification
Source:
Zippelius A
1990
to
1997
|
MD
Education
Source:
Zippelius A
Professional activities (7)
2023
to
present
|
Co-Chair
(Medical Oncology)
Invited position
Source:
Zippelius A
2013
to
2022
|
Deputy Chair
(Medical Oncology)
Invited position
Source:
Zippelius A
2011
to
2012
|
Leading Physician
(Medical Oncology)
Invited position
Source:
Zippelius A
2009
to
2010
|
Senior Physician
(Medical Oncology)
Invited position
Source:
Zippelius A
2007
to
2008
|
Senior Physician
(Medical Oncology)
Invited position
Source:
Zippelius A
2004
to
2006
(Resident)
Invited position
Source:
Zippelius A
1997
to
2000
|
Resident
(Hematology & Oncology)
Invited position
Source:
Zippelius A
Funding (33)
2024
to
2027
|
Grant
Swiss National Science Foundation
(Bern, CH)
Source:
Zippelius A
2023
to
2024
|
Grant
Krebsliga Beider Basel
(Basel, CH)
Source:
Zippelius A
2022
to
2024
|
Grant
Roche (Switzerland)
(Basel, CH)
Source:
Zippelius A
2021
to
2025
|
Grant
University Hospital of Basel
(Basel, CH)
Source:
Zippelius A
2021
to
2025
|
Grant
EU Horizon 2020 Research and Innovation Programme
(Brussels, BE)
Source:
Zippelius A
2021
to
2024
|
Grant
Swiss Cancer League
(Bern, CH)
Source:
Zippelius A
2021
to
2024
|
Grant
HORIZON EUROPE Framework Programme
(Brussels, BE)
Source:
Zippelius A
2021
to
2023
|
Grant
Eidgenössische Technische Hochschule Zürich
(Zurich, CH)
Source:
Zippelius A
2021
to
2022
|
Grant
Novartis (Switzerland)
(Basel, CH)
Source:
Zippelius A
2021
to
2022
|
Grant
Krebsliga Beider Basel
(Basel, CH)
Source:
Zippelius A
2020
to
2023
|
Grant
HORIZON EUROPE Framework Programme
(Brussels, BE)
Source:
Zippelius A
2020
to
2023
|
Grant
Swiss National Science Foundation
(Bern, CH)
Source:
Zippelius A
2020
to
2020
|
Grant
Swiss National Science Foundation
(Bern, CH)
Source:
Zippelius A
2019
to
2023
|
Grant
Roche (Switzerland)
(Basel, CH)
Source:
Zippelius A
2019
to
2020
|
Grant
Krebsliga Beider Basel
(Basel, CH)
Source:
Zippelius A
2018
to
2019
|
Grant
Krebsliga Beider Basel
(Basel, CH)
Source:
Zippelius A
2017
to
2021
|
Grant
Swiss National Science Foundation
(Bern, CH)
Source:
Zippelius A
2017
to
2021
|
Grant
Eidgenössische Technische Hochschule Zürich
(Zurich, CH)
Source:
Zippelius A
2017
to
2019
|
Grant
Kommission für Technologie und Innovation
(Bern, CH)
Source:
Zippelius A
2016
to
2019
|
Grant
Gateway for Cancer Research
(Schaumburg, US)
Source:
Zippelius A
2016
to
2018
|
Grant
Swiss National Science Foundation
(Bern, CH)
Source:
Zippelius A
2016
to
2018
|
Grant
Krebsliga Schweiz
(Bern, CH)
Source:
Zippelius A
2016
to
2017
|
Grant
Krebsliga Beider Basel
(Basel, CH)
Source:
Zippelius A
2014
to
2018
|
Grant
Roche (Switzerland)
(Basel, CH)
Source:
Zippelius A
2014
to
2018
|
Grant
Wilhelm Sander Stiftung
(Munich, DE)
Source:
Zippelius A
2014
to
2018
|
Grant
Swiss National Science Foundation
(Bern, CH)
Source:
Zippelius A
2014
to
2015
|
Grant
Krebsliga Beider Basel
(Basel, CH)
Source:
Zippelius A
2011
to
2013
|
Grant
Krebsliga Beider Basel
(Basel, CH)
Source:
Zippelius A
2011
to
2012
|
Grant
Krebsliga Beider Basel
(Basel, CH)
Source:
Zippelius A
2010
to
2014
|
Award
Swiss National Science Foundation
(Bern, CH)
Source:
Zippelius A
2004
to
2007
|
Grant
Krebsforschung Schweiz
(Bern, CH)
Source:
Zippelius A
2003
to
2008
|
Grant
Deutsche Forschungsgemeinschaft
(Bonn, DE)
Source:
Zippelius A
2000
to
2003
|
Grant
Deutsche Forschungsgemeinschaft
(Bonn, DE)
Source:
Zippelius A